Pioneering Personalized Medicine for RARE DISEASES

We are dedicated to reversing the course of rare diseases through the power of advanced cell and gene therapies. While traditional chemical treatments often merely manage symptoms, our mission is to deliver personalized, transformative solutions that target the root cause. We strive to rewrite the prognosis for patients with critical, unmet medical needs who have no conventional treatment options.

Horizon Europe Teaming for Excellence

CREATIC is Horizon Europe Teaming for Excellence project submitted in 9/2022. Masaryk University has established a partnership with Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig University and Copenhagen University to establish R&D centre of excellence focused on Advanced therapy medicinal products (ATMP). The strategic objectives of the project aim to use a grant of €15 million for 6 years in order to create an excellent facility for ATMP R&D focused on undiagnosed untreatable rare diseases, paediatric patients with high-risk tumours, and adult cancer patients suitable for ATMP treatment.

PARTNERSHIP

Fraunhofer IZI is strategic partner of CREATIC in particular for the research and development of cell and gene therapies paired with expert training and exchange. Read more.

https://creatic.muni.cz/strategic-partnerships/partnership-with-leipzig-university

Leipzig University is a key partner in the CREATIC project, contributing its expertise in cutting-edge research, education, and innovation. Read more.

Partnership with University of Copenhagen

https://creatic.muni.cz/strategic-partnerships/partnership-with-university-of-copenhagen

In the CREATIC project, the University of Copenhagen brings expertise in social sciences and humanities, biomedical law, ethics, and data protection. Read more.

Creating pathways to available cell and gene therapy for rare diseases

CREATIC draws on decades of experience in the research, development and manufacture of pharmaceuticals at the Large Research Infrastructure CZECRIN. It offers a comprehensive range of services and support that are essential for the successful implementation of clinical trials, especially in the field of rare diseases and the development of advanced therapy medicinal products.